|
2019 Journal Article Differential effects of Down's syndrome and Alzheimer's neuropathology on default mode connectivityWilson, Liam R., Vatansever, Deniz, Annus, Tiina, Williams, Guy B., Hong, Young T., Fryer, Tim D., Nestor, Peter J., Holland, Anthony J. and Zaman, Shahid H. (2019). Differential effects of Down's syndrome and Alzheimer's neuropathology on default mode connectivity. Human Brain Mapping, 40 (15) hbm.24720, 4551-4563. doi: 10.1002/hbm.24720 |
|
2019 Journal Article Delineating the topography of amyloid-associated cortical atrophy in Down syndromeMak, Elijah, Padilla, Concepcion, Annus, Tiina, Wilson, Liam R., Hong, Young T., Fryer, Tim D., Coles, Jonathan P., Aigbirhio, Franklin I., Menon, David K., Nestor, Peter J., Zaman, Shahid H. and Holland, Anthony J. (2019). Delineating the topography of amyloid-associated cortical atrophy in Down syndrome. Neurobiology of Aging, 80, 196-202. doi: 10.1016/j.neurobiolaging.2019.02.018 |
|
2019 Journal Article The atrophy pattern in Alzheimer-related PPA is more widespread than that of the frontotemporal lobar degeneration associated variantsPreiß, Daniel, Billette, Ornella V., Schneider, Anja, Spotorno, Nicola and Nestor, Peter J. (2019). The atrophy pattern in Alzheimer-related PPA is more widespread than that of the frontotemporal lobar degeneration associated variants. NeuroImage: Clinical, 24 101994, 101994. doi: 10.1016/j.nicl.2019.101994 |
|
2019 Journal Article Toward in vivo determination of peripheral nervous system immune activity in amyotrophic lateral sclerosisSchreiber, Stefanie, Schreiber, Frank, Garz, Cornelia, Debska-Vielhaber, Grazyna, Assmann, Anne, Perosa, Valentina, Petri, Susanne, Dengler, Reinhard, Nestor, Peter and Vielhaber, Stefan (2019). Toward in vivo determination of peripheral nervous system immune activity in amyotrophic lateral sclerosis. Muscle and Nerve, 59 (5), 567-576. doi: 10.1002/mus.26444 |
|
2019 Journal Article The BDNF Val66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer’s diseaseFranzmeier, Nicolai, Ren, Jinyi, Damm, Alexander, Monté-Rubio, Gemma, Boada, Mercè, Ruiz, Agustín, Ramirez, Alfredo, Jessen, Frank, Düzel, Emrah, Rodríguez Gómez, Octavio, Benzinger, Tammie, Goate, Alison, Karch, Celeste M., Fagan, Anne M., McDade, Eric, Buerger, Katharina, Levin, Johannes, Duering, Marco, Dichgans, Martin, Suárez-Calvet, Marc, Haass, Christian, Gordon, Brian A., Lim, Yen Ying, Masters, Colin L., Janowitz, Daniel, Catak, Cihan, Wolfsgruber, Steffen, Wagner, Michael, Milz, Esther ... Ewers, Michael (2019). The BDNF Val66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer’s disease. Molecular Psychiatry, 26 (2), 614-628. doi: 10.1038/s41380-019-0404-6 |
|
2019 Journal Article The concept of regularization: resolving the problem of surface dyslexia in semantic variant primary progressive aphasia across different languagesBillette, Ornella V., Preib, Daniel and Nestor, Peter J. (2019). The concept of regularization: resolving the problem of surface dyslexia in semantic variant primary progressive aphasia across different languages. Neuropsychology, 34 (3), 298-307. doi: 10.1037/neu0000611 |
|
2018 Journal Article Significance of CSF NfL and tau in ALSSchreiber, Stefanie, Spotorno, Nicola, Schreiber, Frank, Acosta-Cabronero, Julio, Kaufmann, Jörn, Machts, Judith, Debska-Vielhaber, Grazyna, Garz, Cornelia, Bittner, Daniel, Hensiek, Nathalie, Dengler, Reinhard, Petri, Susanne, Nestor, Peter J. and Vielhaber, Stefan (2018). Significance of CSF NfL and tau in ALS. Journal of Neurology, 265 (11), 2633-2645. doi: 10.1007/s00415-018-9043-0 |
|
2018 Journal Article European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensusNobili, F., Arbizu, J., Bouwman, F., Drzezga, A., Agosta, F., Nestor, P., Walker, Z., Boccardi, M. and for the EANM-EAN Task Force for the Prescription of FDG-PET for DementingNeurodegenerative Disorders (2018). European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus. European Journal of Neurology, 25 (10), 1201-1217. doi: 10.1111/ene.13728 |
|
2018 Journal Article Quantitative susceptibility MRI to detect brain iron in amyotrophic lateral sclerosisAcosta-Cabronero, Julio, Machts, Judith, Schreiber, Stefanie, Abdulla, Susanne, Kollewe, Katja, Petri, Susanne, Spotorno, Nicola, Kaufmann, Joern, Heinze, Hans-Jochen, Dengler, Reinhard, Vielhaber, Stefan and Nestor, Peter J. (2018). Quantitative susceptibility MRI to detect brain iron in amyotrophic lateral sclerosis. Radiology, 289 (1), 180112-203. doi: 10.1148/radiol.2018180112 |
|
2018 Journal Article Differential involvement of forearm muscles in ALS does not relate to sonographic structural nerve alterationsSchreiber, Stefanie, Schreiber, Frank, Debska-Vielhaber, Grazyna, Garz, Cornelia, Hensiek, Nathalie, Machts, Judith, Abdulla, Susanne, Dengler, Reinhard, Petri, Susanne, Nestor, Peter J. and Vielhaber, Stefan (2018). Differential involvement of forearm muscles in ALS does not relate to sonographic structural nerve alterations. Clinical Neurophysiology, 129 (7), 1438-1443. doi: 10.1016/j.clinph.2018.04.610 |
|
2018 Journal Article Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementiaBoccardi, Marina, Festari, Cristina, Altomare, Daniele, Gandolfo, Federica, Orini, Stefania, Nobili, Flavio, Frisoni, Giovanni B., EANM-EAN Task Force, Agosta, Federica, Arbizu, Javier, Bouwman, Femke, Drzezga, Alexander, Nestor, Peter and Walker, Zuzana (2018). Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia. European Journal of Nuclear Medicine and Molecular Imaging, 45 (9), 1470-1486. doi: 10.1007/s00259-018-4024-1 |
|
2018 Journal Article Clinical utility of FDG PET in Parkinson's disease and atypical parkinsonism associated with dementiaWalker, Zuzana, Gandolfo, Federica, Orini, Stefania, Garibotto, Valentina, Agosta, Federica, Arbizu, Javier, Bouwman, Femke, Drzezga, Alexander, Nestor, Peter, Boccardi, Marina, Altomare, Daniele, Festari, Cristina, Nobili, Flavio and EANM-EAN Task Force for the recommendation of FDG PET for Dementing Neurodegenerative Disorders (2018). Clinical utility of FDG PET in Parkinson's disease and atypical parkinsonism associated with dementia. European journal of nuclear medicine and molecular imaging, 45 (9), 1534-1545. doi: 10.1007/s00259-018-4031-2 |
|
2018 Journal Article Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s diseaseDrzezga, Alexander, Altomare, Daniele, Festari, Cristina, Arbizu, Javier, Orini, Stefania, Herholz, Karl, Nestor, Peter, Agosta, Federica, Bouwman, Femke, Nobili, Flavio, Walker, Zuzana, Frisoni, Giovanni Battista, Boccardi, Marina and EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders (2018). Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease. European Journal of Nuclear Medicine and Molecular Imaging, 45 (9), 1-10. doi: 10.1007/s00259-018-4032-1 |
|
2018 Journal Article Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasiaBouwman, Femke, Orini, Stefania, Gandolfo, Federica, Altomare, Daniele, Festari, Cristina, Agosta, Federica, Arbizu, Javier, Drzezga, Alexander, Nestor, Peter, Nobili, Flavio, Walker, Zuzana, Morbelli, Silvia, Boccardi, Marina and EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders (2018). Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia. European Journal of Nuclear Medicine and Molecular Imaging, 45 (9), 1526-1533. doi: 10.1007/s00259-018-4034-z |
|
2018 Journal Article Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementiaNestor, Peter J., Altomare, Daniele, Festari, Cristina, Drzezga, Alexander, Rivolta, Jasmine, Walker, Zuzana, Bouwman, Femke, Orini, Stefania, Law, Ian, Agosta, Federica, Arbizu, Javier, Boccardi, Marina, Nobili, Flavio, Frisoni, Giovanni Battista and EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders (2018). Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia. European Journal of Nuclear Medicine and Molecular Imaging, 45 (9), 1509-1525. doi: 10.1007/s00259-018-4035-y |
|
2018 Journal Article Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disordersNobili, Flavio, Festari, Cristina, Altomare, Daniele, Agosta, Federica, Orini, Stefania, Van Laere, Koen, Arbizu, Javier, Bouwman, Femke, Drzezga, Alexander, Nestor, Peter, Walker, Zuzana, Boccardi, Marina and EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders (2018). Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders. European Journal of Nuclear Medicine and Molecular Imaging, 45 (9), 1557-1566. doi: 10.1007/s00259-018-4030-3 |
|
2018 Journal Article Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington's diseaseAgosta, Federica, Altomare, Daniele, Festari, Cristina, Orini, Stefania, Gandolfo, Federica, Boccardi, Marina, Arbizu, Javier, Bouwman, Femke, Drzezga, Alexander, Nestor, Peter, Nobili, Flavio, Walker, Zuzana, Pagani, Marco and EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders (2018). Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington's disease. European Journal of Nuclear Medicine and Molecular Imaging, 45 (9), 1546-1556. doi: 10.1007/s00259-018-4033-0 |
|
2018 Journal Article Clinical utility of FDG-PET for the clinical diagnosis in MCIArbizu, Javier, Festari, Cristina, Altomare, Daniele, Walker, Zuzana, Bouwman, Femke, Rivolta, Jasmine, Orini, Stefania, Barthel, Henryk, Agosta, Federica, Drzezga, Alexander, Nestor, Peter, Boccardi, Marina, Frisoni, Giovanni Battista, Nobili, Flavio and EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders (2018). Clinical utility of FDG-PET for the clinical diagnosis in MCI. European Journal of Nuclear Medicine and Molecular Imaging, 45 (9), 1-12. doi: 10.1007/s00259-018-4039-7 |
|
2018 Journal Article Prefrontal cortical thickness in motor neuron diseaseMachts, Judith, Cardenas-Blanco, Arturo, Acosta-Cabronero, Julio, Kaufmann, Joern, Loewe, Kristian, Kasper, Elisabeth, Schuster, Christina, Prudlo, Johannes, Vielhaber, Stefan and Nestor, Peter J. (2018). Prefrontal cortical thickness in motor neuron disease. NeuroImage: Clinical, 18, 648-655. doi: 10.1016/j.nicl.2018.03.002 |
|
2018 Journal Article Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer's diseaseFranzmeier, Nicolai, Düzel, Emrah, Jessen, Frank, Buerger, Katharina, Levin, Johannes, Duering, Marco, Dichgans, Martin, Haass, Christian, Suárez-Calvet, Marc, Fagan, Anne M, Paumier, Katrina, Benzinger, Tammie, Masters, Colin L, Morris, John C, Perneczky, Robert, Janowitz, Daniel, Catak, Cihan, Wolfsgruber, Steffen, Wagner, Michael, Teipel, Stefan, Kilimann, Ingo, Ramirez, Alfredo, Rossor, Martin, Jucker, Mathias, Chhatwal, Jasmeer, Spottke, Annika, Boecker, Henning, Brosseron, Frederic, Falkai, Peter ... Ewers, Michael (2018). Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer's disease. Brain : A Journal of Neurology, 141 (4), 1186-1200. doi: 10.1093/brain/awy008 |
